Cite
HARVARD Citation
Secord, A. et al. (n.d.). TP019/#1556 PICCOLO: an open-label, single arm, phase 2 study of mirvetuximab soravtansine in recurrent platinum sensitive, high-grade epithelial ovarian cancers with high folate-alpha expression. International journal of gynecological cancer. pp. A232-A233. [Online].